Sale of tranScrip to Palatine Impact

Deal typeM&A & Private Equity & Transaction Services
IndustryLife Sciences

BDO has acted as lead financial advisor to the partners of tranScrip Partners LLP on the sale of the trade and assets of the business to newco funded by a significant minority investment from Palatine Impact Fund.

tranScrip’s unique, highly skilled teams combine in-depth pharmaceutical expertise and functional competencies which allow them to lead and deliver successful development, registration and launch of new medicines across multiple therapeutic areas, including oncology, infectious diseases, respiratory medicine and rare diseases.

The deal is a landmark for tranScrip, underpinning its growth as a leading specialist service provider.